Global Market Size, Forecast, and Trend Highlights Over 2025-2037
HLA Typing for Transplant Market size was over USD 853.48 million in 2024 and is projected to reach USD 1.86 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of HLA typing for transplant is evaluated at USD 898.46 million.
The market is projected to witness a significant growth owing to rising transplant failures which led an upsurge to match the organ transplant feasibility before the surgery to avoid any kind of loss. Factors such as a rise in the number of transplantation procedures and the number of older adult organ donors are anticipated to support the development of the global market. According to the World Health Organization, around 100,800 solid organ transplants are performed every year worldwide, out of which 69 400 are kidney transplants (46% from living donors), 20 200 are liver transplants (14.6% from living donors), 5400 are heart transplants, 3400 are lung transplants and 2400 are pancreas transplants. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purposes is estimated to drive the global market over the forecast period.
HLA Typing for Transplant Sector: Growth Drivers and Challenges
Growth Drivers
Escalating Number of Transplantation Procedures to Enhance the Global Market
HLA typing for the transplant market is projected to observe notable growth owing to the rising numbers of transplantation procedures and an increase in the number of older adult organ donors. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purpose is estimated to drive the global market over the forecast period. Furthermore, a notable gap between demand and supply of organ donations resulting in escalated patient waiting time coupled with increasing awareness levels due to government and non-government organizations is estimated to fuel the market over the forecast period.
Challenges
High Cost of Devices and Stringent Rules Norms
The global HLA typing for the transplant market is projected to hindered by factors such as high costs associated with molecular HLA typing, stringent policies, and norms coupled with a limited number of medical centers for organ donation and transplantation procedures.
HLA Typing for Transplant Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.2% |
|
Base Year Market Size (2024) |
USD 853.48 million |
|
Forecast Year Market Size (2037) |
USD 1.86 billion |
|
Regional Scope |
|
HLA Typing for Transplant Segmentation
The HLA typing for transplant market is segmented by technology, by-products, by application & by end-user, out of which, the molecular assay of technology sector segment is anticipated to hold leading shares in the market on account of the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis. On the contrary, the diagnostic segment of the application sector accounted for the largest share owing to the rising adoption of molecular assay procedures for pathogen detection & histocompatibility testing, and the increasing incidence of chronic diseases. Additionally, independent reference laboratories segment of the end-user sector is estimated to witness a robust growth owing to the increasing number of research & development activities outsourced by pharmaceutical & biotechnology, rapid modernization and automation of diagnostic laboratories, and the growing number of organ transplantation procedures.
Our in-depth analysis of the global market includes the following segments:
By Technology |
|
By Products |
|
|
Application |
|
|
End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportHLA Typing for Transplant Industry - Regional Synopsis
Based on geographically, the HLA typing for transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.
North America industry is poised to account for largest revenue share by 2037, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.
Companies Dominating the HLA Typing for Transplant Landscape
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Immucor, Inc.
- Illumina, Inc.
- CareDx, Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Biofortuna Limited
- Takara Bio Inc.
- Omixon Inc.
In the News
Author Credits: Radhika Pawar
- Report ID: 2629
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT
